Avanti Polar Lipids is a brand that specializes in developing innovative lipid-based products for research and pharmaceutical product development. With over 50 years of experience, Avanti has established itself as the world leader in the field, collaborating with the research, pharmaceutical, and diagnostic industries to advance science and improve lives. Driven by a passion for pure lipids, Avanti offers a wide range of lipid products and services, including cGMP manufacturing, analytical services, lipodomics, and equipment.

Their commitment to quality and integrity sets them apart from other companies in the industry. Avanti's team of highly trained experts provide technical partnerships, from product design to clinical development, ensuring safe and sustainable practices. Avanti's rich history began in 1967 when Dr.

Walter A. Shaw founded the company in Richmond, Virginia. Since then, they have expanded their operations and facilities, partnering with major players in the industry.

In 2020, Avanti was acquired by Croda International Plc, enabling them to further expand their life sciences products and pharmaceutical services. Today, Avanti Polar Lipids continues to drive innovation in lipid technology, offering a diverse portfolio of over 2000 unique lipids, antibodies, and lipid research tools